Regine Brokamp
Chief Operating Officer at Selexis SA
Profile
Regine Brokamp is currently the Chief Operating Officer at Selexis SA since 2010.
Prior to this, she worked as a Principal at Micromet AG and the Max-Planck-Institute for Molecular Genetics.
Regine Brokamp active positions
Companies | Position | Start |
---|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Chief Operating Officer | - |
Former positions of Regine Brokamp
Companies | Position | End |
---|---|---|
Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Regine Brokamp